Literature DB >> 19421721

Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation.

Kathryn Loving1, Noeris K Salam, Woody Sherman.   

Abstract

We have developed a method that uses energetic analysis of structure-based fragment docking to elucidate key features for molecular recognition. This hybrid ligand- and structure-based methodology uses an atomic breakdown of the energy terms from the Glide XP scoring function to locate key pharmacophoric features from the docked fragments. First, we show that Glide accurately docks fragments, producing a root mean squared deviation (RMSD) of <1.0 A for the top scoring pose to the native crystal structure. We then describe fragment-specific docking settings developed to generate poses that explore every pocket of a binding site while maintaining the docking accuracy of the top scoring pose. Next, we describe how the energy terms from the Glide XP scoring function are mapped onto pharmacophore sites from the docked fragments in order to rank their importance for binding. Using this energetic analysis we show that the most energetically favorable pharmacophore sites are consistent with features from known tight binding compounds. Finally, we describe a method to use the energetically selected sites from fragment docking to develop a pharmacophore hypothesis that can be used in virtual database screening to retrieve diverse compounds. We find that this method produces viable hypotheses that are consistent with known active compounds. In addition to retrieving diverse compounds that are not biased by the co-crystallized ligand, the method is able to recover known active compounds from a database screen, with an average enrichment of 8.1 in the top 1% of the database.

Mesh:

Substances:

Year:  2009        PMID: 19421721     DOI: 10.1007/s10822-009-9268-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  33 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Fragment-based lead discovery using X-ray crystallography.

Authors:  Michael J Hartshorn; Christopher W Murray; Anne Cleasby; Martyn Frederickson; Ian J Tickle; Harren Jhoti
Journal:  J Med Chem       Date:  2005-01-27       Impact factor: 7.446

Review 4.  Comparing protein-ligand docking programs is difficult.

Authors:  Jason C Cole; Christopher W Murray; J Willem M Nissink; Richard D Taylor; Robin Taylor
Journal:  Proteins       Date:  2005-08-15

5.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.

Authors:  Steven L Dixon; Alexander M Smondyrev; Eric H Knoll; Shashidhar N Rao; David E Shaw; Richard A Friesner
Journal:  J Comput Aided Mol Des       Date:  2006-11-24       Impact factor: 3.686

6.  A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors.

Authors:  Nicolas Moitessier; Eric Therrien; Stephen Hanessian
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

7.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

8.  An alternative method for the evaluation of docking performance: RSR vs RMSD.

Authors:  Dilmurat Yusuf; Andrew M Davis; Gerard J Kleywegt; Stefan Schmitt
Journal:  J Chem Inf Model       Date:  2008-07-04       Impact factor: 4.956

9.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

Authors:  M D Eldridge; C W Murray; T R Auton; G V Paolini; R P Mee
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

10.  A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.

Authors:  Y C Martin
Journal:  J Med Chem       Date:  1981-03       Impact factor: 7.446

View more
  34 in total

1.  Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.

Authors:  Bill R Miller; Adrian E Roitberg
Journal:  J Mol Graph Model       Date:  2013-08-16       Impact factor: 2.518

Review 2.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

3.  Long-range electrostatic complementarity governs substrate recognition by human chymotrypsin C, a key regulator of digestive enzyme activation.

Authors:  Jyotica Batra; András Szabó; Thomas R Caulfield; Alexei S Soares; Miklós Sahin-Tóth; Evette S Radisky
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

4.  Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening.

Authors:  Arindam Chatterjee; Stephen J Cutler; Robert J Doerksen; Ikhlas A Khan; John S Williamson
Journal:  Bioorg Med Chem       Date:  2014-09-28       Impact factor: 3.641

5.  Targeting the Autophagy Specific Lipid Kinase VPS34 for Cancer Treatment: An Integrative Repurposing Strategy.

Authors:  Poornimaa Murali; Kanika Verma; Thanyada Rungrotmongkol; Perarasu Thangavelu; Ramanathan Karuppasamy
Journal:  Protein J       Date:  2021-01-05       Impact factor: 2.371

6.  Development of energetic pharmacophore for the designing of 1,2,3,4-tetrahydropyrimidine derivatives as selective cyclooxygenase-2 inhibitors.

Authors:  Deepak Lokwani; Reecha Shah; Santosh Mokale; Padma Shastry; Devanand Shinde
Journal:  J Comput Aided Mol Des       Date:  2012-01-05       Impact factor: 3.686

7.  Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction.

Authors:  Insun Park; Ashwini M Londhe; Ji Woong Lim; Beoung-Geon Park; Seo Yun Jung; Jae Yeol Lee; Sang Min Lim; Kyoung Tai No; Jiyoun Lee; Ae Nim Pae
Journal:  J Comput Aided Mol Des       Date:  2017-09-14       Impact factor: 3.686

8.  Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15.

Authors:  Xin Wang; Pádraig D'Arcy; Thomas R Caulfield; Aneel Paulus; Kasyapa Chitta; Chitralekha Mohanty; Joachim Gullbo; Asher Chanan-Khan; Stig Linder
Journal:  Chem Biol Drug Des       Date:  2015-05-27       Impact factor: 2.817

9.  Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo.

Authors:  Amber L Fifield; Paul D Hanavan; Douglas O Faigel; Eduard Sergienko; Andrey Bobkov; Nathalie Meurice; Joachim L Petit; Alysia Polito; Thomas R Caulfield; Erik P Castle; John A Copland; Debabrata Mukhopadhyay; Krishnendu Pal; Shamit K Dutta; Huijun Luo; Thai H Ho; Douglas F Lake
Journal:  Mol Cancer Ther       Date:  2019-10-01       Impact factor: 6.261

10.  Homology modeling, docking and structure-based pharmacophore of inhibitors of DNA methyltransferase.

Authors:  Jakyung Yoo; José L Medina-Franco
Journal:  J Comput Aided Mol Des       Date:  2011-06-10       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.